Clinical Trial Update: Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fludarabine phosphate, radiation therapy, and rituximab followed by rituximab maintenance in high-risk chronic lymphocytic leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Prolymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Fludarabine phosphate (Fludarabine phosphate)
• Rituximab (rituximab)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-07-11